Galapagos Partners With Gilead on Gamgertamig, Unlocks $500M Cash and Eyes 2027 Registrational Trials [Yahoo! Finance]
Galapagos NV - American Depositary Shares (GLPG)
Last galapagos nv - american depositary shares earnings: 10/24 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
glpg.com/company-overview
Company Research
Source: Yahoo! Finance
the companies splitting an upfront component and milestone payments (including references to roughly $1.675 billion and up to $500 million in milestones) and Galapagos eligible for up to $100 million in development milestones. The deal amends the legacy OLCA and “unlocks” an additional $500 million of Galapagos cash (including up to $150 million potentially available for return of capital), while Gilead will hold global commercialization rights outside Greater China and Galapagos will receive 20%–23% royalties. Clinically, Gamgertamig is in phase 1b with 60 autoimmune patients treated (over 160 across all trials), has Fast Track and Orphan designations for hemolytic anemia and ITP, aims to identify a go-forward dose/schedule by end-2026 and could enter registrational studies “as early as .” Interested in Galapagos NV? Here are five stocks we like better. Galapagos (NASDAQ:GLPG) said it has entered into a binding collaboration agreement with Gilead focused on Gamgertamig, a BCM
Show less
Read more
Impact Snapshot
Event Time:
GLPG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GLPG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GLPG alerts
High impacting Galapagos NV - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GLPG
News
- Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases [Yahoo! Finance]Yahoo! Finance
- Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune DiseasesGlobeNewswire
- Galapagos Announces Nomination of Gino Santini to its Board of DirectorsGlobeNewswire
- Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ MeetingsGlobeNewswire
- Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases [Yahoo! Finance]Yahoo! Finance
GLPG
Earnings
- 2/23/26 - Beat
GLPG
Sec Filings
- 3/31/26 - Form 6-K
- 3/30/26 - Form 6-K
- 3/26/26 - Form 20-F
- GLPG's page on the SEC website